0001179110-13-011144.txt : 20130701
0001179110-13-011144.hdr.sgml : 20130701
20130701163308
ACCESSION NUMBER: 0001179110-13-011144
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130701
FILED AS OF DATE: 20130701
DATE AS OF CHANGE: 20130701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Esperion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001434868
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
BUSINESS PHONE: 734-862-4840
MAIL ADDRESS:
STREET 1: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
FORMER COMPANY:
FORMER CONFORMED NAME: HDL THERAPEUTICS INC
DATE OF NAME CHANGE: 20080513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NOHRA GUY P
CENTRAL INDEX KEY: 0001198330
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 13945038
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHAMPSI FARAH
CENTRAL INDEX KEY: 0001198321
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 13945039
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alta Partners Management VIII, LLC
CENTRAL INDEX KEY: 0001399894
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 13945040
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-362-4022
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alta Partners VIII, L.P.
CENTRAL INDEX KEY: 0001399763
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35986
FILM NUMBER: 13945041
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-362-4022
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
4
1
edgar.xml
FORM 4 -
X0306
4
2013-07-01
0
0001434868
Esperion Therapeutics, Inc.
ESPR
0001399763
Alta Partners VIII, L.P.
ONE EMBARCADERO CENTER
37TH FLOOR
SAN FRANCISCO
CA
94111
0
0
1
0
0001399894
Alta Partners Management VIII, LLC
ONE EMBARCADERO CENTER
37TH FLOOR
SAN FRANCISCO
CA
94111
0
0
1
0
0001198321
CHAMPSI FARAH
ONE EMBARCADERO CENTER
37TH FLOOR
SAN FRANCISCO
CA
94111
0
0
1
0
0001198330
NOHRA GUY P
ONE EMBARCADERO CENTER,
37TH FLOOR
SAN FRANCISCO
CA
94111
0
0
1
0
Common Stock
2013-07-01
4
C
0
1816475
A
1816475
I
See footnote
Common Stock
2013-07-01
4
P
0
235714
14.00
A
2052189
I
See footnote
Series A Preferred Stock
2013-07-01
4
C
0
1816475
0
D
Common Stock
1816475
0
I
See footnote
Warrant to Purchase Preferred Stock
1
2013-07-01
4
J
0
497666
0
D
2018-02-12
Series A Preferred Stock
497666
0
I
See footnote
Warrant to Purchase Common Stock
6.99
2013-07-01
4
J
0
71237
0
A
2018-02-12
Common Stock
71237
71237
I
See footnote
The Series A Preferred Stock was automatically converted into Common Stock on a 6.986-for-1 basis upon the closing of the Issuer's initial public offering without payment of further consideration and had no expiration date.
These securities are held of record by Alta Partners VIII, L.P. ("APVIII"). Alta Partners Management VIII, LLC ("APMVIII") is the general partner of APVIII. Guy Nohra, Daniel Janney and Farah Champsi are managing directors of APMVIII and exercise shared voting and investment power with respect to the shares owned by APVIII. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his or its proportionate pecuniary interest therein. Mr. Janney, as a director of the Issuer, files Section 16 reports separately.
Upon the closing of the Issuer's initial public offering, this warrant to purchase shares of Series A Preferred Stock automatically converted on a 6.986-for-1 basis into a warrant to purchase shares of Common Stock, and the exercise price automatically adjusted accordingly. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrant and the change in exercise price.
The warrant is immediately exercisable.
By Alta Partners Management VIII, LLC, by /s/ Guy Nohra, managing director
2013-07-01
/s/ Daniel Janney, managing director
2013-07-01
/s/ Guy Nohra, managing director
2013-07-01
/s/ Farah Champsi, managing director
2013-07-01